Dorostkar et al. emphasized the effectiveness of a STING activator paired with CpG-C adjuvants alongside an HPV16 E7 vaccine, which suppressed tumor proliferation and increased cytokine levels, such as IFN-γ and IL-4 [26]. Here, STING1 is linked to neoplasm.